文献速递瓣膜外科

Tri-Ad Adams三尖瓣成形环的中期结果

Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

本研究回顾性分析248例使用Tri-Ad Adams环行三尖瓣成形的患者,中位年龄64.0岁,EuroSCORE II中位4.3%。术后即刻三尖瓣反流≥中度仅1例(0.4%),早期死亡14例(5.6%);Kaplan-Meier分析4年免于全因死亡率和免于中重度三尖瓣反流率分别为96.9%和91.6%。结论认为该环早期和中期结果良好,需进一步研究确认长期结果。

要点

  • 术后即刻三尖瓣反流≥中度仅1例(0.4%),早期死亡14例(5.6%)。
  • 4年免于全因死亡率和免于中重度三尖瓣反流率分别为96.9%和91.6%。
  • 无三尖瓣再手术、环脱落或显著三尖瓣狭窄(跨瓣压差≥5 mmHg)事件。

核心结论

  • 使用Tri-Ad Adams环行三尖瓣成形在早期和中期均显示出良好结果,需进一步研究确认长期结果。

主要发现

  • 中位年龄64.0岁(四分位距56.0-71.5),中位EuroSCORE II为4.3%(2.7-7.5%),37例(14.9%)有心脏手术史。
  • 三尖瓣反流2-3级占63.7%,中位三尖瓣环直径为3.3 cm(2.8-3.6)。
  • 同期手术包括二尖瓣置换160例(64.5%)、二尖瓣修复75例(30.2%)、主动脉瓣置换72例(29.0%)和迷宫手术170例(68.5%)。
  • 术后即刻三尖瓣反流≥中度1例(0.4%),早期死亡14例(5.6%);主要并发症包括低心排综合征18例(0.3%)、急性肾损伤14例(5.6%)和永久起搏器植入15例(6.0%)。
  • Kaplan-Meier分析4年免于全因死亡率和免于中重度三尖瓣反流率分别为96.9%和91.6%;无三尖瓣再手术、环脱落或显著三尖瓣狭窄(跨瓣压差≥5 mmHg)事件。

临床怎么用

  • 对于需行三尖瓣成形的患者,Tri-Ad Adams环可作为选择之一,其早期和中期结果良好。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Tri-Ad Adams tricuspid annuloplasty ring is a recent innovative prosthesis characterized by a semi-rigid central component and fully flexible extremities. The goal of this study was to assess the short-term and mid-term results following implantation of the Tri-Ad Adams ring. METHODS: A retrospective analysis was conducted on patients who underwent tricuspid annuloplasty using the Tri-Ad Adams ring between August 2016 and October 2021. RESULTS: Our study enrolled a total of 248 participants. The median age was 64.0 (interquartile range: 56.0-71.5) years. The median EuroSCORE II was 4.3% (2.7-7.5%), with 37 patients (14.9%) having a history of cardiac operations. Tricuspid regurgitation of grade 2-3 was observed in 63.7% of cases, and the median tricuspid annular diameter was 3.3 (2.8-3.6) cm. Concurrent procedures included mitral valve replacement (n = 160, 64.5%), mitral valve repair (n = 75, 30.2%), aortic valve replacement (n = 72, 29.0%) and the maze procedure (n = 170, 68.5%). Immediate postoperative tricuspid regurgitation≥moderate was present in 1 patient (0.4%). Early death occurred in 14 patients (5.6%). Major complications included low cardiac output syndrome (n = 18, 0.3%), acute kidney injury (n = 14, 5.6%) and permanent pacemaker placement (n = 15, 6.0%). According to the Kaplan-Meier analysis, the 4-year rates of freedom from overall mortality and moderate-to-severe tricuspid regurgitation were 96.9% and 91.6%, respectively. There were no incidents of tricuspid valve reoperations, ring detachment or significant tricuspid stenosis (trans-tricuspid valve gradient ≥ 5 mmHg). CONCLUSIONS: Tricuspid annuloplasty utilizing the Tri-Ad Adams ring demonstrated favourable outcomes in both the early and midterm periods. Further studies are warranted to confirm the long-term results.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lee H, Kim J, Jung JH, et al. Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38995834. doi:10.1093/icvts/ivae131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。